Conduit Pharmaceuticals Inc. (CDT)
NASDAQ: CDT · Real-Time Price · USD
2.460
-0.030 (-1.20%)
At close: Jun 17, 2025, 4:00 PM
2.400
+0.100 (4.35%)
Pre-market: Jun 18, 2025, 5:21 AM EDT

Conduit Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-19.4-17.8-0.54-4.89-3.66
Depreciation & Amortization
0.650.46---
Other Amortization
0.930.93---
Loss (Gain) From Sale of Investments
-0.01-0.01-0.130.08
Stock-Based Compensation
1.641.830.2--
Other Operating Activities
5.695.05-4.631.570.07
Change in Accounts Payable
0.61.230.22--
Change in Other Net Operating Assets
-1.75-1.37-2.730.61.36
Operating Cash Flow
-11.65-9.68-7.73-2.27-2.15
Capital Expenditures
-0.06-0.05---
Investment in Securities
0.010.01---
Other Investing Activities
--0.73-0.18-
Investing Cash Flow
-0.05-0.040.73-0.18-
Short-Term Debt Issued
-3.232.29--
Long-Term Debt Issued
---1.110.69
Total Debt Issued
3.233.232.291.110.69
Short-Term Debt Repaid
--0.78---
Total Debt Repaid
-2.91-0.78---
Net Debt Issued (Repaid)
0.322.452.291.110.69
Issuance of Common Stock
11.573.50.151.341.21
Other Financing Activities
0.110.118.49--
Financing Cash Flow
11.996.0710.932.451.9
Foreign Exchange Rate Adjustments
-0.01-0.020.300
Net Cash Flow
0.29-3.674.23--0.25
Free Cash Flow
-11.71-9.73-7.73-2.27-2.15
Free Cash Flow Per Share
-106.19-168.37-170.67-90.77-
Cash Interest Paid
0.170.080.12--
Levered Free Cash Flow
-15.62-5.65---
Unlevered Free Cash Flow
-15.57-5.64---
Change in Net Working Capital
7.35-1.92---
Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q